• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • HIV/AIDS

    In Nigeria, HIV self-testing has stakeholders at a policy impasse

    With HIV cases dropping, Nigeria plans to shift to a more cost-effective self-testing strategy, but stakeholders are at odds over the effect this could have on key populations.

    By Paul Adepoju // 21 October 2020

    IBADAN, Nigeria — For around $5 on Konga.com, one of Nigeria’s major e-commerce platforms, Nigerians can buy an oral HIV self-test kit. After ordering the product, Devex found that the kit was easy to use, but the package contained no information about where to get treatment, counseling, confirmation, or any other post-testing services following a positive result.

    Starting in January 2021, Nigeria will centralize and harmonize its HIV/AIDS program, and a key component of this approach is to prioritize self-testing.

    This is more cost-effective than community testing. But rights groups representing gay men — one of the communities worst affected by HIV in Nigeria — fear it could erode the fragile gains made in HIV control among the group. Self-testing does not ensure that follow-up services and treatments are offered, and discriminatory laws and attitudes mean that gay men face particular challenges in accessing these services.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Social/Inclusive Development
    • Trade & Policy
    • Nigeria
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Paul Adepoju

      Paul Adepojupauladepoju

      Paul Adepoju is a Nigeria-based Devex Contributing Reporter, academic, and author. He covers health and tech in Africa for leading local and international media outlets including CNN, Quartz, and The Guardian. He's also the founder of healthnews.africa. He is completing a doctorate in cell biology and genetics and holds several reporting awards in health and tech.

    Search for articles

    Related Stories

    Global HealthWhy ‘integration’ has become a ‘dirty word’ in HIV programming

    Why ‘integration’ has become a ‘dirty word’ in HIV programming

    Global HealthUS funding cuts risk spread of hepatitis

    US funding cuts risk spread of hepatitis

    Global HealthA month after stop-work order, Uganda’s HIV response in chaos

    A month after stop-work order, Uganda’s HIV response in chaos

    Global HealthWill infants finally have access to a highly effective HIV drug?

    Will infants finally have access to a highly effective HIV drug?

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 4
      How is China's foreign aid changing?
    • 5
      2024 US foreign affairs funding bill a 'slow-motion gut punch'
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement